A large cohort of patients who initiated statin or fibrate therapy was followed for the occurrence of new-onset rhabdomyolysis. Crude analyses indicated increased rhabdomyolysis risk on treatment ...

We identified 1,116,805 statin and/or fibrate initiators who met eligibility criteria from January 1, 1998, through December 31, 2007. Of these, 86.6% were statin initiators, 12.9% were fibrate ...